Integra LifeSciences investor relations material

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instrumentsfor use in neurosurgery, extremity reconstruction, and general surgery. It offers tissue ablation products that are used to treat soft tissue abnormalities, including peripheral nerve sheath tumors; uterine fibroids; adipose tissue removal; treating cancerous or non-cancerous prostate lesions; and percutaneous needle-based treatments for lung disease.